Clinical Trials Browser

Phase 2 × Terminated × GSK2141795 × Clear all

NCT01907815 2018-04-06

Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Acute Myeloid Leukemia

Phase 2 Terminated

24 enrolled 6 charts

Other hematologic neoplasm

Leukemia, Myeloid, Acute